Polycystic Ovary Syndrome Renamed to Polyendocrine Metabolic Ovarian Syndrome
Polycystic Ovary Syndrome (PCOS) is being renamed to Polyendocrine Metabolic Ovarian Syndrome (PMOS). This change reflects a shift in medical understanding, acknowledging that the condition is a systemic metabolic and endocrine disorder rather than one limited to ovarian cysts, which many affected women do not actually have. Advocates and medical experts, including the PCOS Society of India, argue that the new name will provide a clearer pathway to diagnosis and treatment for the estimated 170 million women globally. While some organizations are urging health bodies like the NHS to update patient information quickly, the transition aims to reduce misdiagnosis and highlight the role of male hormones and metabolic health.
Prefer swipe-first reading?
Install the app to keep reading with faster loads and a smoother mobile experience.
Sources
From PCOS to PMOS: How renaming a prevalent women’s disorder will improve countless women’s lives
Women suffering from irregular periods, acne, weight gain and other symptoms will now potentially have a clearer pathway to diagnosis and treatment following the name change of a common female ...
Over 800,000 Women in the UK Have PMDD, Yet 90% Are Misdiagnosed—Here's What's Going Wrong
Premenstrual dysphoric disorder, a debilitating condition which affects approximately 824,000 UK women and people assigned female at birth, was only formally recognised in the World Health ...
Fact Checks
Related news
Experts Advise Cutting Ultra-Processed Foods for Better Gut and Heart Health
Multiple dietitians emphasize the critical need to reduce consumption of specific ultra-processed foods (UPFs) due to their potential link to poor gut health, increased heart disease risk, and higher rates of certain cancers. While most experts advocate for a whole-foods approach, some sources suggest that labeling all UPFs as detrimental may be misleading, noting that certain 'demonized' junk foods might still play a role in weight management.
Senate Passes Funding Bill, Blocking White House Overhaul of Federal Science Grants
The US Senate voted to fund the government through December 11, 2026, passing a measure that explicitly blocks new White House regulations concerning federal grant funding. Advocates for scientific integrity argue that the proposed changes—which affect areas like cancer research and graduate student training—could subject medical research to political litmus tests rather than judging them by their public health impact.
JPS Health Network Faces Prolonged Computer Outage, Diverting Ambulances and Impacting Care
JPS Health Network has been dealing with an extended technology failure, leading to significant operational disruptions and requiring the rerouting of ambulances from its facilities. The network confirmed that systems were taken offline following the detection of 'suspicious activity.' Despite the widespread outage, JPS spokespeople maintain that the hospital remains open for patients, though sources report staff are relying on manual, paper-based processes to continue care.
Studies Link Certain Hormonal Contraceptives to Increased Brain Tumor Risk
Multiple studies and reports are examining whether specific types of hormonal contraceptives, including Depo-Provera, may increase the risk of slow-growing brain tumors known as meningiomas. While these drugs remain vital components of reproductive care globally, the controversy involves ongoing legal scrutiny and calls for clearer scientific data. Patients and doctors are advised to discuss individual risk factors and alternative contraceptive options with a healthcare provider.
Joe Biden's Cancer Has Spread To Bones, Son Reports
Former President Joe Biden's prostate cancer has reportedly worsened and metastasized to his bones and other organs, according to his son, Hunter Biden. Sources indicate the disease progression is causing him considerable physical distress and pain. Hunter Biden has been speaking publicly about the severity of his father’s condition, detailing how the spread of the Stage 4 cancer limits his mobility and overall quality of life.
New Guidelines Stress Personalized Testing and Genetic Factors in Heart Health
Leading cardiology associations are updating guidelines to recommend stricter LDL targets and emphasizing comprehensive, personalized risk assessments for heart disease. Beyond standard lipid panels, experts urge testing for specific genetic risk factors, including Lipoprotein(a) (Lp(a)). This highlights that diet alone may not determine cardiovascular risk, requiring a deeper look into individual genetics.
Take Yomuyo with you
Download the mobile app for personalized headlines and quick access to breaking stories.